Research is the engine that drives us toward better understanding MS, better treating MS, and one day, curing MS. My guest on the podcast is Dr. Larry Sherman, who plays a vital role on the front lines of MS research. We're talking with Dr. Sherman about some of his most significant research and his unique research lab.      We're also talking about two important victories for MS Activists. We'll tell you about the EMA approval of Gilenya for treating pediatric MS, the FDA approval of a generic for Aubagio, new technology that will enable people with MS to pilot their wheelchairs by flexing a couple of facial muscles, and the rehab technique that can benefit Olympic athletes and people living with MS.   We have a lot to talk about! Are you ready for RealTalk MS?! ___________

MS Activists Have Something to Celebrate   0:22

National Neurological Conditions Surveillance System Will Study Data for MS 4:48

European Medicines Agency Approves Gilenya for Pediatric MS  6:41

FDA Approves Generic for Aubagio  8:21

New Technology Lets You Pilot a Wheelchair By Flexing Facial Muscles  9:32

Motor Imagery with Verbal Cues & Music May Lead to Improved Walking, Fatigue & Quality of Life for People Living with MS  11:31

My Interview with Dr. Larry Sherman  15:34 

___________

LINKSIf your podcast app doesn’t allow you to click on these links, you’ll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

National MS Society: Get Involved & Advocate For Change

Limbitless Solutions Project Xavier

STUDY: Effects and Mechanisms of Differently Cued and Non-Cued Motor Imagery in People with Multiple Sclerosis: A Randomised Controlled Trial

Oregon National Primate Research Center

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 67 Hosted By: Jon Strum Guest: Dr. Larry Sherman

Tags: MS, MultipleSclerosis, MSsociety, ACA, MSActivist, Gilenya, Aubagio, Limbitless3D, RealTalkMS